Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy.

Journal of Biomedicine & Biotechnology
Catarina MadeiraJoaquim M S Cabral

Abstract

Mesenchymal stem cells (MSCs) hold a great promise for application in several therapies due to their unique biological characteristics. In order to harness their full potential in cell-or gene-based therapies it might be advantageous to enhance some of their features through gene delivery strategies. Accordingly, we are interested in developing an efficient and safe methodology to genetically engineer human bone marrow MSC (BM MSC), enhancing their therapeutic efficacy in Regenerative Medicine. The plasmid DNA delivery was optimized using a cationic liposome-based reagent. Transfection efficiencies ranged from approximately 2% to approximately 35%, resulting from using a Lipid/DNA ratio of 1.25 with a transgene expression of 7 days. Importantly, the number of plasmid copies in different cell passages was quantified for the first time and approximately 20,000 plasmid copies/cell were obtained independently of cell passage. As transfected MSC have shown high viabilities (>90%) and recoveries (>52%) while maintaining their multipotency, this might be an advantageous transfection strategy when the goal is to express a therapeutic gene in a safe and transient way.

References

Nov 1, 2002·Biochemical and Biophysical Research Communications·Hiroyuki KamiyaHideyoshi Harashima
May 23, 2003·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Marit HellumKristian Berg
Jan 1, 1995·Biotechnology Advances·B R Glick
Feb 18, 2004·Annals of Biomedical Engineering·Anna R Derubeis, Ranieri Cancedda
Oct 20, 2004·Journal of Cellular and Molecular Medicine·D BakshR S Tuan
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rebecca Y KlingerLaura E Niklason
Jun 10, 2006·Advanced Drug Delivery Reviews·Xiujuan Zhang, W T Godbey
Jun 23, 2006·Advanced Drug Delivery Reviews·Michelle D Kofron, Cato T Laurencin
Apr 5, 2007·The Journal of Gene Medicine·Adriano R AzzoniDuarte M F Prazeres
Oct 5, 2007·Molecular Biotechnology·Elisabete CarapuçaFilipe J M Mergulhão
Nov 6, 2007·Journal of Cellular and Molecular Medicine·Pascale V GuillotDame Julia Polak
Nov 23, 2007·Advanced Drug Delivery Reviews·M Ian Phillips, Yao Liang Tang
Nov 27, 2007·Advanced Drug Delivery Reviews·Yi LaiThomas Linn
Nov 28, 2007·Experimental Biology and Medicine·Lei YeEugene K W Sim
Feb 5, 2008·Biosensors & Bioelectronics·Jeong Ah KimJun Keun Chang
Apr 5, 2008·Stem Cells·Gwendal Lazennec, Christian Jorgensen
Jun 6, 2008·Gene Therapy·D Schaffert, E Wagner
Aug 30, 2008·Stem Cells and Development·Torben HelledieSimon M Cool
Dec 17, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·José Luís SantosHelena Tomás
Feb 13, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Richard N CohenFrancis C Szoka

❮ Previous
Next ❯

Citations

Jan 13, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangDavid V Schaffer
Feb 27, 2014·Biotechnology & Genetic Engineering Reviews·Fiona WegmanJacqueline Alblas
Jan 28, 2014·International Journal of Molecular Sciences·Robert D WyseJulien Rossignol
Jun 14, 2013·BioMed Research International·Youjin HuDesheng Liang
Aug 28, 2014·International Journal of Molecular Sciences·Nur Shuhaidatul Sarmiza Abdul HalimBadrul Hisham Yahaya
Aug 12, 2015·Biotechnology Progress·Seyed Mohammad Ali Hosseini RadMajid Sadeghizadeh
Feb 6, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Surya K MallapragadaHoward E Gendelman
Nov 4, 2015·Frontiers in Neuroscience·Nafiseh Nafissi, Marianna Foldvari
Oct 20, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Abby M KellyAngela K Pannier
Jan 2, 2014·BioMed Research International·Leah A Marquez-Curtis, Anna Janowska-Wieczorek
Jan 19, 2018·Biotechnology Letters·Talita Giacomet de CarvalhoUrsula Matte
Feb 2, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Narottam LamichhaneJaved Mahmood
Mar 30, 2018·The Journal of Biological Chemistry·Nandini MondalRobert Sackstein
Nov 14, 2018·Journal of Radiation Research·Michelle A BylickyRegina M Day
Aug 6, 2016·Angewandte Chemie·Kegan S SunderlandChuanbin Mao
Nov 14, 2019·Pharmaceutics·Marcin MakowskiNuno C Santos
Jan 25, 2019·Journal of Biological Engineering·Andrew HamannAngela K Pannier
May 18, 2020·International Journal of Molecular Sciences·Arnaud BianchiElmira Arab-Tehrany
Dec 18, 2020·Frontiers in Bioengineering and Biotechnology·Benjamin GantenbeinDevina Purmessur
Apr 11, 2021·Biotechnology and Bioengineering·Enrique Azuaje-HualdeLourdes Basabe-Desmonts
Sep 10, 2014·Journal of the American Chemical Society·Megan E MuroskiGeoffrey F Strouse
Mar 19, 2019·ACS Applied Materials & Interfaces·Alexander S TiminBoris V Afanasyev
Dec 21, 2018·ACS Applied Materials & Interfaces·Yingjun YangGuoping Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry
PCR
fluorescence
FACS
Assay
genetic modification

Software Mentioned

CellQuest

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.